Thema: US7473241013
PYXS, US7473241013
stock-5275746_1920(1).jpg - Foto: THN
Pyxis Oncology stock faces wide analyst targets despite losses
Pyxis Oncology stock carries a Moderate Buy consensus from ten firms. The clinical-stage biotech remains unprofitable and highly speculative.
ad-hoc-news.de, heute 03:25 Uhr
PYXS, US7473241013
Pyxis Oncology stock: Wells Fargo keeps USD 19.00 target ...
Wells Fargo rates Pyxis Oncology stock Buy at a USD 19.00 target on October 16, 2026. The offering raised USD 110.0 million.
ad-hoc-news.de, 23.10.26 05:15 Uhr
PYXS, US7473241013
RBC maintains USD 6.00 target for Pyxis Oncology stock
The October 1 offering brought USD 110.0 million upfront. Pyxis Oncology stock has a USD 114.0 million market value on October 15, 2026.
ad-hoc-news.de, 16.10.26 04:34 Uhr
